Related Experiment Video

Updated: Apr 18, 2026

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
12:42

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

10.4K

Veterinary oncology clinical trials: design and implementation

Douglas H Thamm1, David M Vail2

  • 1Flint Animal Cancer Center, Colorado State University, 300 West Drake Road, Fort Collins, CO 80523-1620, USA.

Veterinary Journal (London, England : 1997)
|January 14, 2015
PubMed

Insights

Veterinary oncology is exploring new cancer treatments for pets. This review guides the design and execution of clinical trials for novel cancer therapies in animals, informing human research.

Area of Science:

  • Veterinary Medicine
  • Oncology
  • Translational Research

Background:

  • Growing interest in evaluating novel cancer therapies in pet animals with spontaneous cancer.
  • Includes veterinary therapeutics and agents informing human clinical trial design.
  • Understanding clinical evaluation stages is crucial for veterinary oncology literature interpretation.

Purpose of the Study:

  • To outline considerations for designing and conducting oncology clinical trials in animals.
  • To discuss recent adaptations in trial designs for enhanced data generation.
  • To provide a framework for interpreting veterinary oncology research.

Main Methods:

  • Review of existing methodologies in oncology clinical trial design.
  • Analysis of adaptations and modifications to standard trial phases.
  • Focus on generating timely and meaningful clinical data in veterinary oncology.

Main Results:

  • Provides a comprehensive overview of oncology clinical trial phases.
  • Highlights key considerations for trial design and conduct in veterinary patients.
  • Discusses innovative approaches to improve data acquisition and interpretation.

Conclusions:

  • Effective clinical trial design is essential for advancing veterinary oncology.
  • Data from pet animals can significantly inform human cancer research.
  • This review serves as a guide for researchers and clinicians in veterinary oncology.
Keywords:
CanineClinical trialOncologyTherapeutic agentsTumor

More Related Videos

Operating Procedures of the Electrochemotherapy for Treatment of Tumor in Dogs and Cats06:32

Operating Procedures of the Electrochemotherapy for Treatment of Tumor in Dogs and Cats

Published on: October 24, 2016

28.1K
Ex Vivo Treatment Response of Primary Tumors and/or Associated Metastases for Preclinical and Clinical Development of Therapeutics08:29

Ex Vivo Treatment Response of Primary Tumors and/or Associated Metastases for Preclinical and Clinical Development of Therapeutics

Published on: October 2, 2014

15.3K

Related Concept Videos

Clinical Trials01:16

Clinical Trials

Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
11.2K
Clinical Trials: Overview01:11

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
5.5K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.9K
Preclinical Development: Overview01:28

Preclinical Development: Overview

Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
6.6K
Cancer Survival Analysis01:21

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
856
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
10.9K